CombiMatrix Provides Strategic Update
21 avr. 2016 06h00 HE | CombiMatrix Corporation
IRVINE, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
admera_health_final_logo_transparent_final.jpg
Admera Health Launches Molecular Test for Inherited Early Atherosclerosis Diagnosis and Risk
17 mars 2016 07h00 HE | Admera Health, LLC
SOUTH PLAINFIELD, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), a commercial stage New Jersey based Precision Medicine and Digital Health company announced today the...
Cesca Therapeutics to Announce Second Quarter Fiscal 2016 Results and Provide a Status Update to Investors on February 16, 2016
11 févr. 2016 06h00 HE | Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that it will report...
immucor.jpg
Immucor and Sirona Genomics Announce CE Mark for MIA FORA™ NGS HLA Typing Solution
03 févr. 2016 11h41 HE | Immucor, Inc.
NORCROSS, Ga., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, in collaboration with Sirona Genomics, today announced CE Mark...
Oryzon Genomics to Present at the 18th Annual BIO CEO & Investor Conference 2016
02 févr. 2016 08h00 HE | Oryzon
BARCELONA, Spain and CAMBRIDGE, Mass., Feb. 02, 2016 (GLOBE NEWSWIRE) -- Oryzon Genomics (ISIN Code: ES0167733015), a clinical stage biopharmaceutical company leveraging epigenetics to develop...
Data Highlighted From 3 Studies Demonstrate Complementarity of BioNano Genomics’ Next-Generation Mapping to Sequencing
11 janv. 2016 07h00 HE | Bionano Genomics
SAN DIEGO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- BioNano Genomics, the leader in physical genome mapping, today announced data from three studies demonstrating how next-generation mapping (NGM) using...
CollabRx, Inc. Logo
CollabRx Chief Medical Officer to Moderate Panel at Personalized Medicine World Conference (PMWC) 2016
10 déc. 2015 07h00 HE | CollabRx, Inc.
SAN FRANCISCO, Dec. 10, 2015 (GLOBE NEWSWIRE) -- CollabRx, Inc. a leading clinical decision support company and wholly owned subsidiary of Rennova Health, Inc. (NASDAQ:RNVA) today announced that its...
Inform Genomics logo
Inform Genomics Files Provisional Patent Application with United States Patent and Trademark Office (USPTO) -"Systems and Methods for Predicting Treatment-Regimen-Related Outcomes."
05 oct. 2015 08h00 HE | Inform Genomics
Boston, Oct. 5, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products announced...
JAX reseachers, collaborators report on variations in human genome
02 oct. 2015 06h05 HE | The Jackson Laboratory
FARMINGTON, Conn., Oct. 2, 2015 (GLOBE NEWSWIRE) -- A consortium of international researchers, including Charles Lee, Ph.D., professor and scientific director at The Jackson Laboratory for Genomic...
Metabolon and Baylor College of Medicine Show Metabolomics May Play Key Role in Precision Medicine
17 août 2015 17h34 HE | Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, today announced study results indicating that its technology is emerging as an...